Robert Kleszcz

21PUBLICATIONS
38CO-AUTHORS
Sensory systemsCancer therapy (excl. chemotherapy and radiation therapy)Toxicology (incl. clinical toxicology)Molecular targetsChemotherapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Sep 26, 2026
20-Hydroxyecdysone-Loaded Niosomes as a Novel Nano-Therapeutic Platform for Psoriasis: In Vitro Characterization and Danio rerio Toxicity Studies.

|Sep 26, 2026
The Inhibition of Histone Lysine Demethylases Affects Head and Neck Cancer Cell Growth and Response to Cisplatin.

|Aug 27, 2026
Transferosomes Containing 20-Hydroxyecdysone for Psoriasis Treatment: Preparation, Characterization, and In Vitro and In Vivo Toxicity Assessment.

|Sep 13, 2025
The Targeted Inhibition of Histone Lysine Demethylases as a Novel Promising Anti-Cancer Therapeutic Strategy-An Update on Recent Evidence.

Jarosław Paluszczak, Robert Kleszcz

|Oct 25, 2024
Honokiol Is More Potent than Magnolol in Reducing Head and Neck Cancer Cell Growth.

Robert Kleszcz, Dawid Dorna, Maciej Stawny

|Jun 27, 2024
Triple Combinations of Histone Lysine Demethylase Inhibitors with PARP1 Inhibitor-Olaparib and Cisplatin Lead to Enhanced Cytotoxic Effects in Head and Neck Cancer Cells.

Dawid Dorna, Robert Kleszcz, Jarosław Paluszczak

Pageof 4

Frequent Collaborators

12 joint publications

Violetta Krajka-Kuźniak

11 joint publications

Jarosław Paluszczak

5 joint publications

Wanda Baer-Dubowska

5 joint publications

Aleksandra Majchrzak-Celińska